| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 25.706 | 34.507 | 57.036 | 30.252 | 23.882 | 7.277 | 0 |
| Total Income - EUR | - | - | 0 | 29.115 | 39.433 | 75.792 | 34.978 | 35.357 | 9.149 | 1.859 |
| Total Expenses - EUR | - | - | 822 | 24.847 | 34.961 | 86.660 | 32.301 | 38.342 | 17.510 | 1.949 |
| Gross Profit/Loss - EUR | - | - | -822 | 4.268 | 4.471 | -10.868 | 2.676 | -2.985 | -8.361 | -90 |
| Net Profit/Loss - EUR | - | - | -822 | 4.011 | 4.126 | -11.438 | 2.374 | -3.293 | -8.361 | -90 |
| Employees | - | - | 0 | 2 | 2 | 3 | 1 | 1 | 0 | 0 |
Check the financial reports for the company - Nobiotic Pharma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 16 | 38.983 | 33.302 | 27.839 | 22.496 | 7.324 | 5.428 | 3.540 |
| Current Assets | - | - | 54 | 19.793 | 17.774 | 2.393 | 9.582 | 11.490 | 1.238 | 802 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 13.949 | 14.419 | 0 | 5.987 | 6.006 | 336 | 334 |
| Cash | - | - | 54 | 5.844 | 3.355 | 2.393 | 3.595 | 5.484 | 903 | 468 |
| Shareholders Funds | - | - | -756 | 3.269 | 7.332 | -4.245 | -1.777 | -5.076 | -13.421 | -13.436 |
| Social Capital | - | - | 66 | 64 | 63 | 62 | 61 | 61 | 61 | 60 |
| Debts | - | - | 826 | 16.244 | 10.168 | 34.476 | 33.855 | 5.561 | 3.688 | 3.328 |
| Income in Advance | - | - | 0 | 39.263 | 33.577 | 0 | 0 | 18.328 | 16.400 | 14.450 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Nobiotic Pharma Srl